Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses into Clinical Practice

[RSS News Bot]

CONCLUSIONS: Expanding the use of BoNT-A, a predictable, minimally invasive, and affordable treatment to address commonly encountered complaints, is appealing. The authors have found that making patients aware of microtoxin as a treatment option results in increased interest, increased use of BoNT-A, and high satisfaction among appropriately selected patients.

More...